Malignancies and risk of recurrent venous thrombosis

J.F. Timp; Linda E. Flinterman; Astrid van Hylckama Vlieg; Frits R. Rosendaal; Suzanne C. Cannegieter

Article2014

The risk of recurrent venous thrombosis in patients with cancer

J.F. Timp, Linda E. Flinterman, Astrid van Hylckama Vlieg, Saskia le Cessie, Frits R. Rosendaal, Suzanne C. Cannegieter

Thrombosis Research

Article2016

Risk of venous thrombo-embolism in female malignancies: the Scandinavian Thrombosis and Cancer Cohort

Inger Lise Gade, Sigrid K. Brækkan, Inger Anne Næss, John‐Bjarne Hansen, Frits R. Rosendaal, Suzanne C. Cannegieter, Kim Overvad, Hilde Jensvoll, Jens Hammerstrøm, Kristine Blix, Helle Højmark Eriksen, Søren Risom Kristensen, Marianne Tang Severinsen

Letter2012

The influence of prothrombotic laboratory abnormalities on the risk of recurrent venous thrombosis

Daniel Dias Ribeiro, Willem M. Lijfering, Sandhi Maria Barreto, Fabiane Dias Lopes, Giselli de Souza Pires, Frits R. Rosendaal, Suely Meireles Rezende

Thrombosis Research

Article2007

A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS

Astrid van Hylckama Vlieg, Frits R. Rosendaal, Lance A. Bare, André R. Arellano, Barbara Young, Trevor Baglin

Journal of Thrombosis and Haemostasis

Article2007

Response: Homocysteine lowering and recurrent venous thrombosis: the VITRO trial

Martin den Heijer, Henk J. Blom, Frits R. Rosendaal, Gerard M.J. Bos

Blood

Malignancies and risk of recurrent venous thrombosis

Abstract

Discussion(0)

Related publications

The risk of recurrent venous thrombosis in patients with cancer

Risk of venous thrombo-embolism in female malignancies: the Scandinavian Thrombosis and Cancer Cohort

The influence of prothrombotic laboratory abnormalities on the risk of recurrent venous thrombosis

A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS

Response: Homocysteine lowering and recurrent venous thrombosis: the VITRO trial